Targeting a blood stem cell subset shows lasting gene editing
Scientists report how editing a portion of stem cells with CRISPR-Cas9 is sufficient for long-term reactivation of therapeutic haemoglobin.
List view / Grid view
Scientists report how editing a portion of stem cells with CRISPR-Cas9 is sufficient for long-term reactivation of therapeutic haemoglobin.
Researchers have found a specific strain of Helicobacter pylori strongly correlated with stomach cancer...
Study in nonhuman primates traces regeneration of blood and immune systems to 5 percent of transplanted blood stem cells...
A new biomedical tool has been developed using nanoparticles that deliver transient gene changes to targeted cells...